genetics of complex disease: from mouse to man and back
Clicks: 5
ID: 153231
1995
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
1.2
/100
5 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #235 of 250 articles by views in indian journal of pharmacology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 250 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Identification of genes underlying complex traits has been difficult, but combined application of novel methods and mouse models provides new hope. Rare monogenic syndromes, and candidate gene and biochemical approaches are sometimes useful, but each of these approaches also has limitations. Some problems that prevent identification and isolation of genes underlying complex disease can be avoided by the use of whole genome mapping of mouse crosses or of human families. Mice have many advantages for the study of complex disease, including an extensive genetic map. A generic method has recently been developed and applied for detection of quantitative trait loci (QTLs) using whole genome maps of mouse crosses. Availability of more than 200 congenic strains provides another incentive for studies in mice. Congenic strains provide a rich, but previously unexploited, resource for the rapid identification of genes causing complex diseases. A congenic mouse strain is genetically identical to a background strain, except for a small chromosomal region derived from a donor strain. Thus, comparison of a phenotype in a congenic strain with the phenotype in its background strain allows study of the effects of single genes derived from the donor strain, isolated from the effects of other donor strain genes. Application of all or several techniques to complex disease studies in mice and in humans may lead to the identification and understanding of complex diseases whose etiology is currently unknown.
| Reference Key |
warden1995canadiangenetics
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Craig H Warden;Jerome I Rotter |
| Journal | indian journal of pharmacology |
| Year | 1995 |
| DOI |
10.1155/1995/842672
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.